-
公开(公告)号:SG11202112414UA
公开(公告)日:2021-12-30
申请号:SG11202112414U
申请日:2020-05-14
Applicant: VERTEX PHARMA
Inventor: BANDARAGE UPUL KEERTHI , BLIGH CAVAN MCKEON , BOUCHER DIANE , BOYD MICHAEL JOHN , BRODNEY MICHAEL AARON , CLARK MICHAEL PHILIP , DAMAGNEZ VERONIQUE , FANNING LEV TYLER DEWEY , FIMOGNARI ROBERT FRANCIS , FLEMING GABRIELLE SIMONE , GAGNON KEVIN JAMES , GARCIA BARRANTES PEDRO MANUEL , GIACOMETTI ROBERT DANIEL , GIROUX SIMON , GREY JR RONALD LEE , GUIDO SAMANTHA , HALL AMY BETH , HOOD SARAH CAROL , HURLEY DENNIS JAMES , JOHNSON JR , JONES PETER , KESAVAN SARATHY , LAI MEI-HSIU , LIU SIYING , LOOKER ADAM , MAXWELL BRAD , MAXWELL JOHN PATRICK , MEDEK ALES , NUHANT PHILIPPE MARCEL , OVERHOFF KIRK ALAN , RODAY SETU , ROEPER STEFANIE , RONKIN STEVEN M , SAWANT RUPA , SHI YI , SHRESTHA MUNA , SPOSATO MARISA , STAVROPOULOS KATHY , SWETT REBECCA JANE , TANG QING , TAPLEY TIMOTHY LEWIS , THOMSON STEPHEN , XU JINWANG , ZAKY MARIAM , COTTRELL KEVIN MICHAEL
IPC: C07D231/56 , A61K31/4162 , A61K31/429 , A61P1/16 , A61P11/00 , C07D487/04 , C07D498/18 , C07D513/04
Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I):tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.
-
公开(公告)号:MX2021013993A
公开(公告)日:2021-12-10
申请号:MX2021013993
申请日:2020-05-14
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , ROEPER STEFANIE , FANNING LEV TYLER DEWEY , HURLEY DENNIS JAMES , JONES PETER , SHI YI , COTTRELL KEVIN MICHAEL , MAXWELL JOHN PATRICK , RONKIN STEVEN M , GIROUX SIMON , STAVROPOULOS KATHY , BRODNEY MICHAEL AARON , MEDEK ALES , SHRESTHA MUNA , ZAKY MARIAM , NUHANT PHILIPPE MARCEL , BLIGH CAVAN MCKEON , GAGNON KEVIN JAMES , HOOD SARAH CAROL , RODAY SETU , SAWANT RUPA , TANG QING , BANDARAGE UPUL KEERTHI , DAMAGNEZ VERONIQUE , GREY JR RONALD LEE , HALL AMY BETH , SWETT REBECCA JANE , TAPLEY TIMOTHY LEWIS , XU JINWANG , BOUCHER DIANE , BOYD MICHAEL JOHN , CLARK MICHAEL PHILIP , FIMOGNARI ROBERT FRANCIS , FLEMING GABRIELLE SIMONE , GUIDO SAMANTHA , JOHNSON JR MAC ARTHUR , KESAVAN SARATHY , LAI MEI-HSIU , LIU SIYING , MAXWELL BRAD , OVERHOFF KIRK ALAN , SPOSATO MARISA , THOMSON STEPHEN , GARCIA BARRANTES PEDRO , GIACOMETTI ROBERT
IPC: A61K31/429 , A61K31/4162 , A61P1/16 , A61P11/00 , C07D231/56 , C07D487/04 , C07D498/18 , C07D513/04
Abstract: La descripción proporciona compuestos útiles para tratar la deficiencia de alfa-1 antitripsina (AATD), de acuerdo con la fórmula (I), tautómeros de estos, sales farmacéuticamente aceptables de los compuestos, sales farmacéuticamente aceptables de los tautómeros, derivados deuterados de los compuestos, derivados deuterados de los tautómeros y derivados deuterados de las sales, formas sólidas de esos compuestos y procesos para preparar esos compuestos. (ver Fórmula).
-
公开(公告)号:UY38696A
公开(公告)日:2020-11-30
申请号:UY38696
申请日:2020-05-13
Applicant: VERTEX PHARMA
Inventor: JONES PETER , NUHANT PHILIPPE MARCEL , BANDARAGE UPUL KEERTHI , BLIGH CAVAN MCKEON , GAGNON KEVIN JAMES , BOYD MICHAEL JOHN , GIROUX SIMON , GREY JR RONALD LEE , HALL AMY BETH , HOOD SARAH CAROL , HURLEY DENNIS JAMES , JOHNSON JR , KESAVAN SARATHY , LOOKER ADAM , MAXWELL JOHN PATRICK , MEDEK ALES , RODAY SETU , ROEPER STEFANIE , SAWANT RUPA , SHI YI , SWETT REBECCA JANE , TANG QING , TAPLEY TIMOTHY LEWIS , XU JINWANG , BOUCHER DIANE , CLARK MICHAEL PHILIP , DAMAGNEZ VERONIQUE , FANNING LEV TYLER DEWEY , FIMOGNARI ROBERT FRANCIS , FLEMING GABRIELLE SIMONE , GARCIA BARRANTES PEDRO MANUEL , GIACOMETTI ROBERT DANIEL , GUIDO SAMANTHA , LAI MEI-HSIU , LIU SIYING , MAXWELL BRAD , OVERHOFF KIRK ALAN , RONKIN STEVEN M , SHRESTHA MUNA , SPOSATO MARISA , STAVROPOULOS KATHY , THOMSON STEPHEN , ZAKY MARIAM , BRODNEY MICHAEL AARON
IPC: A61P1/16 , A61K31/4162 , A61P11/00 , C07D487/14 , C07D498/18
Abstract: La descripción proporciona compuestos útiles para tratar la deficiencia de alfa-1 antitripsina (AATD), de acuerdo con la fórmula (I), tautómeros de estos, sales farmacéuticamente aceptables de los compuestos, sales farmacéuticamente aceptables de los tautómeros, derivados deuterados de los compuestos, derivados deuterados de los tautómeros y derivados deuterados de las sales, formas sólidas de esos compuestos y procesos para preparar esos compuestos.
-
公开(公告)号:AU2012279046B2
公开(公告)日:2017-08-31
申请号:AU2012279046
申请日:2012-07-03
Applicant: VERTEX PHARMA
Inventor: TANOURY GERALD J , JUNG YOUNG CHUN , MAGDZIAK DEREK , LOOKER ADAM , KLINE BILLIE J , JURCIK VACLAV , DOMINGUEZ OLMO BEATRIZ
IPC: C07D471/04
Abstract: The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of Janus kinases (JAK).
-
公开(公告)号:ES2622154T3
公开(公告)日:2017-07-05
申请号:ES12794811
申请日:2012-11-08
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , LITTLER BENJAMIN , CHOUDHURY ANUSUYA , HARRISON CRISTIAN , VELURI RAVIKANTH , RYAN MICHAEL , JIANG LICONG , LUSS-LUSIS EDUARD
IPC: C07D405/12 , A61K31/405 , A61K31/553 , A61P1/00 , A61P3/00 , A61P11/00 , A61P25/00 , A61P27/00 , A61P35/00 , C07D405/14 , C07D498/04
Abstract: Un compuesto de formula II:**Fórmula** una sal farmaceuticamente aceptable del mismo, en la que independientemente para cada caso: R es H, OH, OCH3 o dos R tomados juntos forman -OCH2 O-o-OCF2 O-; R1 es H o hasta dos alquilo C1-C6; R2 es H o halo; R3 es H o alquilo C1-C6; Y es O o NR4; y R4 es H o alquilo C1-C6.
-
公开(公告)号:NZ595817A
公开(公告)日:2014-03-28
申请号:NZ59581710
申请日:2010-04-27
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , CHEN MINZHANG , JURKAUSKAS VALDAS , TANOURY GERALD J , COCHRAN JOHN E
IPC: C07D209/52 , A61K31/403 , C07D471/08 , C07K7/02
Abstract: 595817 Disclosed herein are processes for preparing a mixture of cis- and trans-octctahydropenta[c]pyrrole-1-carboxylic acids of formula 7, wherein R’ substituents are described in the specification, comprising carboxylation of an azabicyclooctane of formula 6, and equilibrating in the presence of a suitable base wherein the trans-/cis-ratio is greater than 80 to 20, or 90 to 10 or 98 to 2. Also disclosed herein are processes for preparing a compound of formula 4, comprising providing a compound of Formula 7 forming a salt with an optically active amine; crystallizing the salt; esterifying the acid provided in step iii); removing the N-alkoxycarbonyl group to produce (1S,3aR,6aS)-t-butyl-octahydrocyclopenta[c]pyrrole-1-carboxylate, t-butyl ester; reacting the bicyclic aminoester of step v) with a protected amino acid of Formula 26, wherein Z is an amine protecting group, in the presence of a coupling reagent, to produce an amide-ester of Formula 27; removing the protecting group Z from the amide-ester of step vi) to produce the amino compound of Formula 28; reacting the amino compound of Formula 28 with a protected amino acid of Formula 29in the presence of a coupling reagent to produce a tripeptide of Formula 30; removing the protecting group Z in the tripeptide of Formula 30 to produce a free amino-tripeptide of Formula 31; reacting the amino-tripeptide of Formula 31 with pyrazine-2-carboxylic acid in the presence of a coupling reagent to produce an amide-tripeptide ester of Formula 33; hydrolyzing the ester of the amide-tripeptide ester of Formula 33 to produce an amide-tripeptide acid of Formula 34; reacting the amide-tripeptide acid of Formula 34 with an aminohydroxy-amide of Formula 18in the presence of a coupling reagent to produce a hydroxy-tetrapeptide of Formula 35; and oxidizing the hydroxy group of Formula 35 to produce the compound of Formula 4.
-
57.
公开(公告)号:CA2699292A1
公开(公告)日:2009-03-26
申请号:CA2699292
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , FENG YUSHI , HARRISON CRISTIAN , LOOKER ADAM , MUDUNURI PRAVEEN , ROEPER STEFANIE , ZHANG YUEGANG
Abstract: Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide are described herein, including crystalline forms thereof.
-
58.
公开(公告)号:AU2008301907A1
公开(公告)日:2009-03-26
申请号:AU2008301907
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: ZHANG YUEGANG , DEMATTEI JOHN , MUDUNURI PRAVEEN , HARRISON CRISTIAN , LOOKER ADAM , ROEPER STEFANIE , FENG YUSHI
-
公开(公告)号:ZA200607634B
公开(公告)日:2008-01-08
申请号:ZA200607634
申请日:2006-09-12
Applicant: VERTEX PHARMA
Inventor: LOOKER ADAM , TRUDEAU MARTIN , RAMAYA SHARN , RUTHERFORD ALISTAIR , ODONNELL MICHAEL , STUDLEY JOHN R , MORTIMORE MICHAEL , DURRANT STEVEN , CHARRIER JEAN DAMIEN
IPC: A61K38/04 , A61K38/06 , C07D207/16 , C07D209/52 , C07D401/12 , C07D401/14 , C07D405/12 , C07D417/06 , C07D417/12 , C07K5/02 , C07K5/04
Abstract: The present invention provides a compound of formula (I): wherein the variables are as defined herein. The present invention also provides processes for preparing the compounds of formula (I), and intermediates thereof, pharmaceutical compositions comprising those compounds, and methods of using the compounds and compositions.
-
公开(公告)号:NO20076307A
公开(公告)日:2007-12-07
申请号:NO20076307
申请日:2007-12-07
Applicant: VERTEX PHARMA
Inventor: SNOONIAN JOHN R , LOOKER ADAM , ANSELL GRAHAM , BLYTHE TODD A , JONES ANDREW D , LITTLER BENJAMIN , NYCE PHILIP L
IPC: C07C275/42 , C07C271/34 , C07D307/16 , C07D413/12
CPC classification number: C07D307/20 , C07D413/12
-
-
-
-
-
-
-
-
-